I know there will be pitch forks out as soon as I make comment...

I know there will be pitch forks out as soon as I make comment on Cynata, but I will anyway. I just watched a presentation by Cynata, who are in the same space as MSB but deriving stem cells from a single blood donor rather than multiple bone marrow donors and the consistency problems that involves. MSB is clearly in the lead to obtain first approval and first to market, but Cynata seems to have exactly the same potential including in early aGVHD trials; except the process for obtaining "product" looks cheaper, simpler and to be potentially just as effective.

For those who are always shouting "what about the children" re MSB approval, I am sure will rejoice in the fact that we have other companies with potential for success competing with us. Cynata are well advanced and it did cross my mind that they had the potential to overtake us in the future.

I read every day the borne again zeal of many posters here and while I think we can all agree MSB has huge potential, it remains a speculative stock until it isn't!